Category: oxford university press

Heart journal pulls paper for image manipulation

cardresCardiovascular Research has retracted a 2010 paper by a group of prominent cardiology researchers in Brazil.

The reason: Image manipulation — which the authors say didn’t materially affect the conclusions of the paper.

The article, “FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex,” came from a group led by Ana Paula Dalla Costa, from the State University of Campinas.

Here’s the abstract of the study, which has been cited 19 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Heart journal pulls paper for image manipulation

Heart paper will go on, but only in the first of two journals it was published in

Cardiovascular ResearchA cardiovascular group has retracted a conference proceeding abstract, because it too closely resembled a paper they published prior to the conference.

The last author is baffled as to why the journal couldn’t have made that call before they published the abstract.

Here’s the notice for “Increased beta-adrenergic inotropy in ventricular myocardium from Trpm4 knockout mice”: Continue reading Heart paper will go on, but only in the first of two journals it was published in

Publisher updates with more info on staph retraction

cidWe brought you this story last week, about a paper on drug resistant staph being retracted for a lab error. Now, we’ve got an update from Rachel Safer, senior editor for medical journals at Oxford University Press, where the paper was published.

Apparently, the researchers “inadvertently relied upon the use of a test system that was not approved for the microorganism studied in their paper,” leading to the retraction, and the corresponding author of the study wasn’t initially all that responsive:

Continue reading Publisher updates with more info on staph retraction

87% of bugs resistant to antibiotics? Not so fast, as staph paper yanked after staff mistake

What could have been a truly scary study about drug resistant staph infections in hospitals has been retracted due to a lab error.

6.coverResearchers at a community hospital in Pittsburgh claimed that the commonly quoted 3% rate of staph that is resistant to ceftriaxone and sensitive to methicillin was drastically understated. However, an “honest error in the interpretation of a key lab test” called the findings into question.

Here’s the abstract: Continue reading 87% of bugs resistant to antibiotics? Not so fast, as staph paper yanked after staff mistake

Article about alcohol withdrawal withdrawn

A stumble in data preparation earned a retraction for a paper on delirium tremensalcohol_and_alcoholism, a life-threatening side effect of alcohol withdrawal that spans a wide range of symptoms, including hallucinations and seizures.

Though the initial retraction notice was extremely unhelpful, the author stepped in to give us a better picture of the errors that led to the paper’s demise.

Here’s the notice from Alcohol and Alcoholism about “Biochemical Predictors of Delirium Tremens in Patients in Alcohol Withdrawal”:

Continue reading Article about alcohol withdrawal withdrawn

Diabetes researcher who says he will no longer publish now up to five retractions

toth
Cory Toth, via U Calgary

Cory Toth, the University of Calgary diabetes researcher who told us last month he would stop publishing in science following a string of inappropriate manipulations, has retracted another paper.

Here’s the notice in Brain for “Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy:” Continue reading Diabetes researcher who says he will no longer publish now up to five retractions

Author who broke into lab to tamper with investigation now up to half a dozen retractions

Bioconjugate ChemistryKarel Bezouška, the scientist who tried to tamper with an investigation into his work by breaking into a lab refrigerator, has had his fifth and sixth papers retracted.

Here’s the notice from Bioconjugate Chemistry for 2012’s “Dimerization of an Immunoactivating Peptide Derived from Mycobacterial hsp65 Using N-Hydroxysuccinimide Based Bifunctional Reagents Is Critical for Its Antitumor Properties:” Continue reading Author who broke into lab to tamper with investigation now up to half a dozen retractions

Film review by noted critic a rerun, retracted

french cinemaMany devotees of French film consider Jean Renoir’s 1939 La Règle du jeu (The Rules of the Game) to be the best example of the genre, and indeed of movie making writ large.

Bad cut alert: One of the rules of the publishing game is, “ne pas plagier,” which we don’t think we need to translate here.

But that’s something that Robert Cardullo seems to have neglected. Cardullo, of Izmir University of Economics in Turkey, isn’t a nobody in the world of film criticism (you can say movie reviewing if you like, we won’t mind). Here’s a bio from Mellen Press: Continue reading Film review by noted critic a rerun, retracted

Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair

ehj Just 48 hours after publishing an article by Graham Cole and Darrel Francis last week alleging that Don Poldermans‘ scientific misconduct led to the deaths of some 800,000 Europeans over the past five years by tainting clinical guidelines, the European Heart Journal unceremoniously pulled the paper from its website Friday.

Larry Husten at CardioBrief has been on top of the story. According to Husten: Continue reading Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair

We did what? Authors retract paper after forgetting they’d published the same study elsewhere

j antimicrob chemoScientists: Have you ever found it difficult to keep track of all those papers you publish? Who can blame you? So many journals, so much pressure to publish or perish.

That must have been what happened to a quintet of authors from Shanghai who’ve just had to retract an article from the Journal of Antimicrobial Chemotherapy. Here’s the notice (sadly, behind a paywall) [see note at end of post] for “Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment:” Continue reading We did what? Authors retract paper after forgetting they’d published the same study elsewhere